First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38579194.
- Also identified by DOI 10.1200/PO.23.00633 and PMC identifier 11018191.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
First use of AXL-targeting in adenoid cystic carcinoma (ACC); with positive results, ACC now included in AXL studies.
Medical subject headings
- Carcinoma, Adenoid Cystic
- Axl Receptor Tyrosine Kinase